References
- Nelson RE, Saltzman GM, Skalabrin EJ, Demaerschalk BM, Majersik JJ. The cost–effectiveness of telestroke in the treatment of acute ischaemic stroke. Neurology77, 1590–1598 (2011).
- Quinn TJ, Dawson J. Acute ‘strokenomics’: efficacy and economic analyses of alteplase for acute ischaemic stroke. Expert Rev. Pharmacoeconomics Outcomes Res.9, 513–522 (2009).
- Lees KR, Bluhmki E, von Kummer R et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet375, 1695–1703 (2010).
- National Audit Office. Reducing Brain Damage: Faster Access to Better Stroke Care. HC 452 2005–2006. National Audit Office, London, UK (2005).
- Levine SR, Gorman MJ. ‘Telestroke’: the application of telemedicine for stroke. Stroke30, 464–469 (1999).
- Kleindorfer D, Xu Y, Moomaw CJ, Khatri P, Adeoye O, Hornung R. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Stroke40, 3580–3584 (2009).
- Minnerup J, Wersching H, Ringelstein EB et al. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time. Stroke42, 2838–2843 (2011).
- Meyer BC, Raman R, Hemmen T et al. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol.7, 787–795 (2008).
- Schwamm LH, Audebert HJ, Amarenco P et al. Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American heart association. Stroke40, 2635–2660 (2009).
- Demaerschalk BM, Miley ML, Kiernan TJ et al. For the STARR investigators. Stroke telemedicine. Mayo. Clin. Proc.84(1), 53–64 (2009).
- Schwamm LH, Holloway RG, Amarenco P et al. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American heart association/American stroke association. Stroke40, 2616–2634 (2009).
- Audebert HJ, Kukla C, Vatankhah B et al. Comparison of tissue plasminogen activator administration management between telestroke network hospitals and academic stroke centers: the telemedical pilot project for integrative stroke care in Bavaria/Germany. Stroke37, 1822–1827 (2006).
- Johansson T, Wild C. Telemedicine in acute stroke management: systematic review. Int. J. Technol. Assess. Health Care26, 149–155 (2010).
- Quinn TJ, Dawson J, Walters MR, Lees KR. Functional outcome measures in contemporary stroke trials. Int. J. Stroke3, 200–205 (2009).
- Ehlers L, Muskens WM, Lotte GJ, Kjolby M, Andersen G. National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost–effectiveness. CNS Drugs22, 73–81 (2008).
- Luengo-Fernandez R, Gray AM, Rothwell PM. Costs of stroke using patient level data: a critical review of the literature. Stroke40, e18–e23 (2009).
- Sairanen T, Soinila S, Nikkanen M et al. for the Finnish telestroke taskforce. Two years of Finnish telestroke: thrombolysis at spokes equal to that at hub. Neurology76, 1145–1152 (2011).